Anthony Martinelli is Founder and Editor-in-Chief of The Marijuana Herald, a daily marijuana news and information website that launched in 2018. You can reach Anthony at [email protected].
Anthony Martinelli
Author's posts
Aug 16 2024
Medical Marijuana Now Legal in Ukraine
Legislation legalizing medical marijuana in Ukraine officially takes effect today. In February, President Zelenskyy signed the legislation into law, following approval through the nation’s Verkhovna Rada with 248 of the body’s 450 members voting in favor. Under the new law, which moves marijuana from the most prohibitive Schedule I list of drugs to Schedule II, …
Aug 15 2024
North Carolina’s First-Ever Recreational Marijuana Store Opens in Three Weeks for Everyone 21+
In a historic milestone for North Carolina, the state’s first-ever recreational marijuana store is set to open in just three weeks, welcoming all adults aged 21 and older. Operated by the Eastern Band of Cherokee Indians, the marijuana “megastore” is located on tribal lands in the town of Cherokee. The outlet, named the Great Smoky …
Aug 15 2024
Poll: Voters in Wisconsin, Pennsylvania, and Michigan Strongly Favor Legalizing Marijuana and Federal Marijuana Banking Reform
A recent poll conducted by The Tarrance Group shows strong support among likely voters in the key swing states of Michigan, Pennsylvania, and Wisconsin for legalizing marijuana. According to the poll, a significant majority of voters across these states, regardless of political affiliation, are in favor of legalization. Specifically, 64% of voters in Michigan, 58% …
Aug 15 2024
Study: Cannabinoids Show Promise in Treating Periodontal Disease
A study published in the latest issue of the journal Pharmaceutics indicates that cannabinoids may be useful in treating periodontal disease. Titled The Role of Different Types of Cannabinoids in Periodontal Disease: An Integrative Review, the study explores the involvement of cannabinoid receptors in both healthy and inflamed periodontal tissues. In addition to the journal …
Aug 15 2024
North Dakota Voters to Decide on Marijuana Legalization This November with Measure 5
North Dakota voters will have the chance to legalize recreational marijuana this November, as Measure 5 has officially qualified for the ballot. New Economic Frontier, the organization behind the initiative, successfully gathered over 22,000 valid signatures, exceeding the required threshold of 15,582. This gives voters the opportunity to consider the measure this November 5. Measure …
Aug 15 2024
Maryland Achieves Record-Breaking Marijuana Sales in July
There was more legal marijuana sold in July in Maryland than in any previous month. There was a total of $97,917,735 worth of marijuana and marijuana products sold through legal means in July, according to the Maryland Cannabis Administration. Around $70 million of these sales were recreational marijuana products, with medical marijuana patients purchasing the …
Aug 14 2024
New Jersey Commission Mandates Reinstatement and Backpay for Third Jersey City Officer Fired Over Marijuana Use
In a continuing saga over marijuana consumption among law enforcement, Jersey City has faced another legal setback in its attempt to punish officers over their off-the-job marijuana use. On Wednesday, the New Jersey Civil Service Commission mandated the reinstatement of Police Officer Mackenzie Reilly, who was dismissed in August 2023 after a random drug test …
Aug 14 2024
Federal Legislation Would Protect State Psilocybin Laws
Federal legislation that would protect state laws legalizing psilocybin is gaining renewed interest as Massachusetts may soon become the third state to do so. House Resolution 5592, officially titled the “Validating Independence for State Initiatives on Organic Natural Substances (VISIONS) Act,” was introduced last September by Congressmembers Robert Julio Garcia (D-CA), with Rep. Earl Blumenauer …
Aug 14 2024
UC San Francisco Seeks Participants for Three Psilocybin Studies
The University of California, San Francisco (UCSF) is actively recruiting participants for three clinical trials exploring the effects of psilocybin on various mental health conditions, including Alzheimer’s disease and depressions/anxiety associated with advanced cancer. The first study, titled “Psilocybin for Depression and Anxiety in Patients With Advanced Cancer“, will investigate the potential of psilocybin to …
Aug 14 2024
Psilocybin and ADHD: Johns Hopkins Recruiting for New Clinical Trial
Johns Hopkins Medicine is currently seeking participants for a groundbreaking clinical trial investigating the potential effects of psilocybin, the psychoactive compound found in “magic mushrooms”, on adults diagnosed with ADHD. The study, led by Principal Investigator Roland Griffiths, PhD, is open to individuals aged 18-65 who meet the criteria for ADHD. This research aims to …
